NG
BCAX

Norden Group’s Bicara Therapeutics BCAX Stock Holding History

Norden Group’s Portfolio BCAX Stock Details BCAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$265K Buy
+8,911
New +$199K 0.02% 565

Other funds holding BCAX

RTM
Red Tree Management Redwood City, California $147M AUM 202.18% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Norden Group's BCAX Position: Q2 2026 in Review

Norden Group opened a new position in Bicara Therapeutics (BCAX) in Q2 2026: 8,911 shares worth $265K. The stake represents 0.02% of the portfolio and ranks #565 among its holdings.

20 funds tracked by Wall St. Rank hold BCAX as of Q2 2026.

  • Norden Group held 8,911 shares of Bicara Therapeutics worth $265K as of Q2 2026.
  • Bicara Therapeutics was a new Norden Group position in Q2 2026.
  • Bicara Therapeutics made up 0.02% of Norden Group's portfolio in Q2 2026, its #565 holding.
  • 20 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q2 2026.

Based on Norden Group's 13F filing for Q2 2026, filed 29 Jul 2026.